930 related articles for article (PubMed ID: 17144916)
1. Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study.
Jonkers RE; Bantje TA; Aalbers R
Respir Res; 2006 Dec; 7(1):141. PubMed ID: 17144916
[TBL] [Abstract][Full Text] [Related]
2. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction.
van der Woude HJ; Boorsma M; Bergqvist PB; Winter TH; Aalbers R
Pulm Pharmacol Ther; 2004; 17(2):89-95. PubMed ID: 15123230
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study.
Aalbers R; Boorsma M; van der Woude HJ; Jonkers RE
Respir Res; 2010 May; 11(1):66. PubMed ID: 20509942
[TBL] [Abstract][Full Text] [Related]
4. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
5. Relief of dyspnoea by beta2-agonists after methacholine-induced bronchoconstriction.
van der Woude HJ; Postma DS; Politiek MJ; Winter TH; Aalbers R
Respir Med; 2004 Sep; 98(9):816-20. PubMed ID: 15338791
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
[TBL] [Abstract][Full Text] [Related]
7. Relief of methacholine-induced bronchospasm with extrafine beclomethasone dipropionate/formoterol in comparison with salbutamol in asthma.
Singh D; Corradi M; Bindi E; Baronio R; Petruzzelli S; Paggiaro P
Pulm Pharmacol Ther; 2012 Oct; 25(5):392-8. PubMed ID: 22842339
[TBL] [Abstract][Full Text] [Related]
8. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
Haney S; Hancox RJ
Respir Res; 2005 Sep; 6(1):107. PubMed ID: 16168062
[TBL] [Abstract][Full Text] [Related]
9. Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction.
Politiek MJ; Boorsma M; Aalbers R
Eur Respir J; 1999 May; 13(5):988-92. PubMed ID: 10414394
[TBL] [Abstract][Full Text] [Related]
10. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
Papi A; Corradi M; Pigeon-Francisco C; Baronio R; Siergiejko Z; Petruzzelli S; Fabbri LM; Rabe KF
Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
[TBL] [Abstract][Full Text] [Related]
11. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T
Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
[TBL] [Abstract][Full Text] [Related]
12. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
Lindberg A; Szalai Z; Pullerits T; Radeczky E
Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
[TBL] [Abstract][Full Text] [Related]
13. Dose-response protective effect of salbutamol on methacholine airway responsiveness using pressurized metered dose inhalers and Turbuhalers.
Wong AG; O'Byrne PM; Lindbladh C; Inman MD; Stâhl E; Hargreave FE
Can Respir J; 1998; 5(2):119-23. PubMed ID: 9707454
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial.
Tashkin DP; Rennard SI; Martin P; Ramachandran S; Martin UJ; Silkoff PE; Goldman M
Drugs; 2008; 68(14):1975-2000. PubMed ID: 18778120
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of inhaled formoterol in reversing bronchoconstriction.
Rubin AS; Perin C; Pelegrin L; Fernandes JC; da Silva LC
J Bras Pneumol; 2006; 32(3):202-6. PubMed ID: 17273608
[TBL] [Abstract][Full Text] [Related]
16. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma.
Corren J; Korenblat PE; Miller CJ; O'Brien CD; Mezzanotte WS
Clin Ther; 2007 May; 29(5):823-843. PubMed ID: 17697902
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
[TBL] [Abstract][Full Text] [Related]
18. Effect of formoterol with or without budesonide in repeated low-dose allergen challenge.
Dahlén B; Lantz AS; Ihre E; Skedinger M; Henriksson E; Jörgensen L; Ekström T; Dahlén SE; Larsson K
Eur Respir J; 2009 Apr; 33(4):747-53. PubMed ID: 19129280
[TBL] [Abstract][Full Text] [Related]
19. The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction.
Giannini D; Di Franco A; Bacci E; Dente FL; Taccola M; Vagaggini B; Paggiaro P
Chest; 2000 May; 117(5):1319-23. PubMed ID: 10807817
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma.
Balanag VM; Yunus F; Yang PC; Jorup C
Pulm Pharmacol Ther; 2006; 19(2):139-47. PubMed ID: 16009588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
